Dr Arnab Basu, CEO of Kromek

Member Article

Kromek continues sales momentum with $1.15m deal

Durham-based radiation detection technology company Kromek is keeping up its product sale momentum, after being awarded new contracts worth a total of approximately $1.15m.

The firm, which focuses on the medical, security and nuclear markets, will supply its CZT-based detector modules to three current OEM customers, who are worldwide producers and exporters of bone mineral density

The deals will be delivered over the next 24 months, with the majority to be delivered within the next 12 months.

Under the terms of the agreements, Kromek’s detector modules will be incorporated into the OEMs’ systems to produce some of the most accurate imaging to diagnose the strength and health of bones.

The CZT-based diagnostic systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.

Dr Arnab Basu, CEO of Kromek, said: “It is very pleasing to secure double the orders we received from these long-standing customers last year.

“It strengthens our relationship with them and further validates our belief that more and more legacy detection systems are being replaced with BMD diagnostic systems with our CZT detectors.

“The agreements represent the continued healthy conversion of our pipeline into orders as we continue to win new contracts in the medical sector.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →

Enjoy the read? Get Bdaily delivered.

Sign up to receive our daily bulletin, sent to your inbox, for free.

* Occasional offers & updates from selected Bdaily partners

Our Partners